The global chemiluminescence immunoassay (CLIA) analyzers market is characterized with enhanced sensitivity and specificity of automated CLIA analyzers with the ability of multiplexing. The global chemiluminescence immunoassay (CLIA) analyzers market was valued over US$ 4.4 Bn in 2016 and is projected to witness cumulative annual growth rate (CAGR) of over 6.0% from 2017 to 2025 to surpass the value of US$ 7.5 Bn by 2025. The global market is witnessing relatively higher growth owing to characteristic high preference for chemiluminescence immunoassay (CLIA) analyzers among all others immunoassay types.

global chemiluminescence immunoassay analyzers market

The global chemiluminescence immunoassay (CLIA) analyzers market is witnessing continuous innovations in test offerings and wide product portfolio of major as well as local manufacturers. The collaborations among major market players for superior technological advancements in test offerings is likely to drive the growth of global chemiluminescence immunoassay (CLIA) analyzers market during the forecast period. The CLIA technology provides enhanced sensitivity, specificity, improved precision, and reduced incubation, which together increases efficiency of this technique. The method also provides precise results with lower variation and improved comparability with the standards used in the assays. Major manufacturers operating in the market are involved in continuous research & development activities to expand their already wide product portfolio. For instance, On May 23, 2017, DiaSorin S.p.A. announced the launch of new LIAISON test for measuring SHBG (Sex Hormone-Binding Globulin) in human serum and plasma, whereas, emerging players operating in the market are also focusing on introducing new versions of their existing analyzers. Continuous expansion of test offering in high throughput systems along with reduced waiting time and improved results specificity are likely to drive the growth of global CLIA market during the forecast period. However, fragmented consumables market affecting profit margin of major market players, and limited growth of the analyzers segment of the market in developing regions, due to rental use are likely to restrain the growth of the global chemiluminescence immunoassay (CLIA) analyzers market during the forecast period.

Development of integrated analyzers with multiple components and multiplexing modalities with high-throughput and increased sensitivity serves as a major opportunity for the growth in global chemiluminescence immunoassay (CLIA) analyzers market. The chemiluminescence immunoassay (CLIA) analyzers market is witnessing steady demand for combination of process analysis and informatics from modern medical industry into the immunoassay analyzers so as to incorporate various analysis technologies into a single platform. The year 2016 was characterized with such innovations by leading market players which has reduced turnover time, and incubation time, along with enhanced automation level which has further fueled the growing demand of automated chemiluminescence immunoassay (CLIA) analyzers.

The global chemiluminescence immunoassay (CLIA) analyzers market has been segmented on the basis of product, application, end-user, and geography. Among product segments, reagents segment is expected to continue its dominance during the forecast period, owing to relative higher frequency of reagent replacement when compared to analyzer systems. Among applications, endocrine disorders and oncology segments held more than half of the share of the global chemiluminescence immunoassay (CLIA) analyzers market in 2016, in terms of value. The hepatitis and retrovirus application is projected to expand at a relatively higher CAGR in terms of value during the forecast period. Among various end-users, hospitals was the leading end-user in 2016 and is likely to account for leading share during the forecast period.

Geographically, North America captured lion’s share of global chemiluminescence immunoassay (CLIA) analyzers market in 2016. High adoption of advanced technologies, large base of diagnostic laboratories, and growth of pharmaceutical and biotechnology companies are some of the pivotal factors contributing to the major share of North America in the global market. However Asia Pacific is projected to witness a comparatively higher growth rate in terms of value during the forecast period of 2017-2025, due to large patient pool led by increase in incidence of chronic diseases demanding affordable care and early detection measures, and growing focus of key players in emerging markets such as China and India.

Key companies operating in the global chemiluminescence immunoassay (CLIA) analyzers market and profiled in the report include F. Hoffmann-La Roche Ltd., Abbott, Siemens Healthineers, and Beckman Coulter, Inc. (Danaher), among others. Major technological trend observed among the leading players operating in the global chemiluminescence immunoassay analyzers market is the introduction of next-generation integrated immunoassays. For instance, On October 31, 2017, Abbott announced the FDA 510(k) clearance for Alinity ci-series.

Global chemiluminescence immunoassay (CLIA) analyzers market is mainly driven by the rising demand for ultrasensitive diagnosis of disorders along with improved precision and efficiency, and increasing innovations in the new test offerings. The market is witnessing growing trend of introduction of novel tests with technologically advanced detection precision with reduced incubation time at affordable costs, which is anticipated to steer the global chemiluminescence immunoassay (CLIA) analyzers market growth. Significant adoption rate among professional end-users for newly introduced innovative analyzers is likely to drive the market growth, and value added service assistance of these analyzers in terms of rental service agreements serves as major opportunity for the players operating in the global chemiluminescence immunoassay (CLIA) analyzers market.

The market overview section of the report comprises qualitative analysis of the overall chemiluminescence immunoassay (CLIA) analyzers market considering the factors determining the market dynamics such as drivers, restraints and opportunities, and market attractiveness analysis. In addition, such as market opportunity analysis for the product type, application, and end-user, and key industry developments has also been provided. Key industry developments include the major events occurred in past decade and are expected to occur during the forecast period which are likely to affect the market dynamics. The analysis of winning imperatives of top companies has also been provided global chemiluminescence immunoassay (CLIA) analyzers market. The report also covers detailed overview of the global prevalence rates of major diseases in the application areas including, but not limited to endocrine disorders, oncology, infectious diseases, hepatitis & retrovirus, cardiovascular disorders, allergy, autoimmunity, and others. The section technological advancements in the report covers detailed analysis of current technological trends in the global chemiluminescence immunoassay (CLIA) analyzers market. The report also includes a section on healthcare industry overview that deals with the healthcare industry scenario by countries.

The global chemiluminescence immunoassay (CLIA) analyzers market is segmented in terms of product type, application, end-user, and regions. Based on product, the global chemiluminescence immunoassay (CLIA) analyzers market is categorized into analyzers, reagents, and consumables. The segment analyzers is further divided into automated analyzers and semi-automated analyzers. The segment reagents is further bifurcated into enzymatic markers and luminophore markers. On the basis of application, the global chemiluminescence immunoassay (CLIA) analyzers market is classified into endocrine disorders, oncology, infectious diseases, hepatitis & retrovirus, cardiovascular disorders, allergy, autoimmunity, drug discovery & development, and others. Based on end-user segment, the global chemiluminescence immunoassay (CLIA) analyzers market is categorized into hospitals, clinical laboratories, pharmaceutical & biotechnology industries, and others.

Geographically, the global chemiluminescence immunoassay (CLIA) analyzers market has been categorized into five regions namely, North America, Europe, Asia-Pacific, Latin America, and the Middle East & Africa. The market size and forecast for each region has been provided for the period 2015 to 2025, in terms of product type, application, end-user, and countries/sub-regions along with the CAGR (%) for the forecast period 2017 to 2025.

The report also provides a section on the competitive landscape, wherein the market share analysis of leading players in the global chemiluminescence immunoassay (CLIA) analyzers market, in terms of percentage share in 2016 has been discussed. A list of recommendations has also been included for new entrants as well as existing market players to help them establish a strong presence in the market and increase their market share. Major players having presence in the global chemiluminescence immunoassay (CLIA) analyzers market include Abbott, Siemens Healthineers (Siemens AG), F. Hoffmann-La Roche Ltd., Danaher (Beckman Coulter, Inc.), DiaSorin S.p.A., Sysmex Corporation, Randox Laboratories Ltd., Ortho Clinical Diagnostics (a part of Carlyle Group), Shenzhen New Industries Biomedical Engineering Co., Ltd., Tosoh Corporation, among others.

The global chemiluminescence immunoassay (CLIA) analyzers market has been segmented as follows:

  • Global Chemiluminescence Immunoassay (CLIA) Analyzers Market, by Product
    • Analyzers
      • Automated
      • Semi-automated
    • Reagents
      • Luminophore Markers
      • Enzymatic Markers
    • Consumables
       
  • Global Chemiluminescence Immunoassay (CLIA) Analyzers Market, by Application
    • Endocrine Disorders
    • Oncology
    • Infectious Diseases
    • Hepatitis & Retrovirus
    • Cardiovascular Disorders
    • Allergy
    • Autoimmunity
    • Drug Discovery & Development
    • Others
       
  • Global Chemiluminescence Immunoassay (CLIA) Analyzers Market, by End-user
    • Hospitals
    • Clinical Laboratories
    • Pharmaceutical & Biotechnology Industries
    • Others
       
  • Global Chemiluminescence Immunoassay (CLIA) Analyzers Market, by Geography
    • North America
      • U.S.
      • Canada
    • Europe
      • U.K.
      • Germany
      • France
      • Spain
      • Italy
      • Russia
      • Rest of Europe
    • Asia Pacific
      • China
      • Japan
      • India
      • Australia & New Zealand
      • Rest of Asia Pacific
    • Latin America
      • Brazil
      • Mexico
      • Rest of Latin America
    • Middle East & Africa
      • GCC Countries
      • South Africa
      • Rest of Middle East & Africa